Western blotting showed that GSK690693 blocked the miR-29b silencing-induced activation of AKT2/3, HK2 and PKM2, confirming that the miR-29b-AKT axis regulates the activity of key glycolytic enzymes in ovarian cancer cells (Figure 5B). Here, AKT1 is linked to ovarian carcinoma.